Effects of chitosan coating on biocompatibility of Mg-6%Zn-10%Ca3(PO4)2 implant

A Mg-6%Zn-10%Ca3(PO4)2 composite with a chitosan coating was prepared to study its in vivo biodegradation properties. The chitosan dissolved in a 0.2% acetic acid solution was applied on the surface of Mg-6%Zn-10%Ca3(PO4)2 composite specimens and solidified at 60 °C for 30 min to form the coating. The cytotoxicity evaluation of chitosan coated specimens is at level 0, which indicates that such coating is safe for cellular applications. The in vivo tests of chitosan coated composite show that the concentration of metal ions from the composite measured in the venous blood of Zelanian rabbits is less than that from the uncoated composite specimens. The chitosan coating impedes the in vivo degradation of the composite after surgery. The in vivo testing also indicates that the chitosan coated composite is harmless to important visceral organs, including the heart, kidneys and liver of the rabbits. The new bone formation surrounding the chitosan coated composite implant shows that the composite improves the concrescence of the bone tissues. And the chitosan coating is an effective corrosion resistant layer that reduces the hydrogen release of the implant composite, thereby decreasing the subcutaneous gas bubbles formed.